Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-002726
Filing Date
2022-01-10
Accepted
2022-01-10 17:32:01
Documents
1
Period of Report
2022-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6167
  Complete submission text file 0001209191-22-002726.txt   7850
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Riker Lauren Bullaro (Reporting) CIK: 0001545439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 22522171